Orna Therapeutics, Inc. clinical trials
Acquired by Eli Lilly and Company, May 2026 · source ↗
The registry lists 1 studies whose lead sponsor is Orna Therapeutics, Inc. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 16, 2026.
- 1study on the registry
- 1open to participants now
- 1reach primary completion within a year
Before and after it joined Eli Lilly and Company
- First submitted before Orna Therapeutics, Inc. became part of Eli Lilly and Company
- 1
- First submitted after Orna Therapeutics, Inc. became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Coming up
1 of Orna Therapeutics, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- 1DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
The study
- Dec 2026A Study of ORN252 in Healthy ParticipantsNCT07439796
Add it to your calendar (.ics) → With an account.
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Open now1100%
Registry sponsor names on this page
- Orna Therapeutics, Inc.1 study
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Eli Lilly and Company studies →
- A Study of ORN252 in Healthy ParticipantsRecruitingNCT07439796Phase 1
Sponsor listed in the registry: Orna Therapeutics, Inc. · First submitted before Orna Therapeutics, Inc. became part of Eli Lilly and Company